The alterations in CD4+Treg cells across various phases of major depression
Journal of Affective Disorders · 2024-10 · 362 · 485-492
DOI: 10.1016/j.jad.2024.07.037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024-10. Verfasst von Xiaoyu Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi School of Medicine, Jiangnan University, China. Hauptthemen laut MEDLINE: Major Depressive Disorder, T-Lymphocytes, Regulatory, Antidepressive Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Major depression (MD) is recurrent and devastating mental disease with a high worldwide prevalence. Mounting evidence suggests neuroinflammation triggers cellular immune dysregulation, characterized by increased proportions of circulating monocytes, and T helper 17 cells and proinflammatory cytokines, thereby increasing susceptibility to MD. However, there is ambiguity in the findings of clinical studies that investigate CD4+ T regulatory (Treg) cells in MD. METHODS: The proportion of CD4+ Treg cell from blood mononuclear cells was examined using flow cytometry in healthy controls (HCs: n = 96) and patients with first (FEMD: n = 62) or recurrent (RMD: n = 41) disease episodes of MD at baseline (T0; hospital admission) and after a two-week antidepressant treatment (T14). All participants underwent comprehensive neuropsychological assessments. RESULTS: The initial scores on emotional assessments in patients with MD significantly differed from those of HCs. Both FEMD and RMD patients exhibited a significant decrease in CD4+ Treg cell proportion at baseline compared to HCs. Treg cell proportion rose significantly from T0 to T14 in FEMD patients, who responded to antidepressant therapy, whereas no significant changes were observed in FEMD patients in non-response as well as RMD patients. The improvement of 24-item Hamilton Depression Scale was correlate with changes of Treg cell proportion from T0 to T14 in FEMD patients in response, and the change in Treg cell proportion over a 14-day period exhibited an AUC curve of 0.710. CONCLUSIONS: A decrease in the proportion of CD4+ Treg cells points towards immune system abnormalities in patients with MD. Furthermore, our finding suggests that the immune activation state varies across different stages of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuxi School of Medicine, Jiangnan University, China.
- Department of Hematology, Affiliated Hospital of Jiangnan University, China.
- Department of Neurology, Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, China.
- Department of Pathology, Affiliated Hospital of Nantong University, China. Electronic address: liulei19920123@163.com.
- Department of Pharmacy, Affiliated Hospital of Nantong University, China. Electronic address: comic_huarong@163.com.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Yu, X., Ye, L., Liang, H., Li, H., Gao, S., Xu, C., Yang, T., Shi, Y., Liu, L., & Huang, R. (2024). The alterations in CD4+Treg cells across various phases of major depression. Journal of Affective Disorders, 362, 485-492. https://doi.org/10.1016/j.jad.2024.07.037
Vancouver
Yu X, Ye L, Liang H, Li H, Gao S, Xu C, et al. The alterations in CD4+Treg cells across various phases of major depression. Journal of Affective Disorders. 2024;362:485-492. doi:10.1016/j.jad.2024.07.037
BibTeX
@article{Yu2024,
author = {Yu, Xiaoyu and Ye, Long and Liang, Huijun and Li, Heng and Gao, Shulei and Xu, Chenxue and Yang, Tingting and Shi, Yachen and Liu, Lei and Huang, Rongrong},
title = {The alterations in CD4+Treg cells across various phases of major depression},
journal = {Journal of Affective Disorders},
year = {2024},
volume = {362},
pages = {485--492},
doi = {10.1016/j.jad.2024.07.037}
}
EUVIMED